Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind randomized trial of levetiracetam vs valproic acid monotherapy in children with newly diagnosed epilepsy
2010-018284-42Phase 3Terminated
- Sponsor
- University Medical Center Groningen
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in epilepsy comparing Levetiracetam monotherapy with Valproic acid monotherapy (2 arms). Primary endpoint: Retention rate after 52 weeks of treatment. Started Sep 2012; status: terminated.
02
Drugs
levetiracetamvalproic acid
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2010-018284-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018284-42.